Fluctuations in Oxygen Saturation during Synchronized Nasal Intermittent Positive Pressure Ventilation and Nasal High-Frequency Oscillatory Ventilation in Very Low Birth Weight Infants: A Randomized Crossover Trial.
Desaturation
Hypoxemia
Nasal high-frequency oscillatory ventilation
Nasal intermittent positive pressure ventilation
Oxygen saturation target
Preterm infant
Journal
Neonatology
ISSN: 1661-7819
Titre abrégé: Neonatology
Pays: Switzerland
ID NLM: 101286577
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
12
2022
accepted:
21
03
2023
medline:
4
10
2023
pubmed:
3
7
2023
entrez:
2
7
2023
Statut:
ppublish
Résumé
Very low birth weight (VLBW) infants on noninvasive ventilation (NIV) experience frequent fluctuations in oxygen saturation (SpO2) that are associated with an increased risk for mortality and severe morbidities. In this randomized crossover trial, VLBW infants (n = 22) born 22+3 to 28+0 weeks on NIV with supplemental oxygen were allocated on two consecutive days in random order to synchronized nasal intermittent positive pressure ventilation (sNIPPV) and nasal high-frequency oscillatory ventilation (nHFOV) for 8 h. nHFOV and sNIPPV were set to equivalent mean airway pressure and transcutaneous pCO2. Primary outcome was the time spent within the SpO2 target (88-95%). During sNIPPV, VLBW infants spent significantly more time within the SpO2 target (59.9%) than during nHFOV (54.6%). The proportion of time spent in hypoxemia (22.3% vs. 27.1%) and the mean fraction of supplemental oxygen (FiO2) (29.4% vs. 32.8%) were significantly reduced during sNIPPV, while the respiratory rate (50.1 vs. 42.6) was significantly higher. Mean SpO2, SpO2 above the target, number of prolonged (>1 min) and severe (SpO2 <80%) hypoxemic episodes, parameters of cerebral tissue oxygenation using NIRS, number of FiO2 adjustments, heart rate, number of bradycardias, abdominal distension and transcutaneous pCO2 did not differ between both interventions. In VLBW infants with frequent fluctuations in SpO2, sNIPPV is more efficient than nHFOV to retain the SpO2 target and to reduce FiO2 exposure. These results demand more detailed investigations into cumulative oxygen toxicities during different modes of NIV over the weaning period, particularly with regard to consequences for long-term outcomes.
Sections du résumé
BACKGROUND
Very low birth weight (VLBW) infants on noninvasive ventilation (NIV) experience frequent fluctuations in oxygen saturation (SpO2) that are associated with an increased risk for mortality and severe morbidities.
METHODS
In this randomized crossover trial, VLBW infants (n = 22) born 22+3 to 28+0 weeks on NIV with supplemental oxygen were allocated on two consecutive days in random order to synchronized nasal intermittent positive pressure ventilation (sNIPPV) and nasal high-frequency oscillatory ventilation (nHFOV) for 8 h. nHFOV and sNIPPV were set to equivalent mean airway pressure and transcutaneous pCO2. Primary outcome was the time spent within the SpO2 target (88-95%).
RESULTS
During sNIPPV, VLBW infants spent significantly more time within the SpO2 target (59.9%) than during nHFOV (54.6%). The proportion of time spent in hypoxemia (22.3% vs. 27.1%) and the mean fraction of supplemental oxygen (FiO2) (29.4% vs. 32.8%) were significantly reduced during sNIPPV, while the respiratory rate (50.1 vs. 42.6) was significantly higher. Mean SpO2, SpO2 above the target, number of prolonged (>1 min) and severe (SpO2 <80%) hypoxemic episodes, parameters of cerebral tissue oxygenation using NIRS, number of FiO2 adjustments, heart rate, number of bradycardias, abdominal distension and transcutaneous pCO2 did not differ between both interventions.
CONCLUSIONS
In VLBW infants with frequent fluctuations in SpO2, sNIPPV is more efficient than nHFOV to retain the SpO2 target and to reduce FiO2 exposure. These results demand more detailed investigations into cumulative oxygen toxicities during different modes of NIV over the weaning period, particularly with regard to consequences for long-term outcomes.
Identifiants
pubmed: 37393894
pii: 000530409
doi: 10.1159/000530409
pmc: PMC10614494
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
598-606Informations de copyright
© 2023 The Author(s). Published by S. Karger AG, Basel.
Références
Respir Physiol Neurobiol. 2019 Aug;266:121-129
pubmed: 31100375
Int J Mol Sci. 2021 Oct 12;22(20):
pubmed: 34681665
Eur J Pediatr. 2021 Oct;180(10):3151-3160
pubmed: 33890156
Arch Dis Child Fetal Neonatal Ed. 2011 Mar;96(2):F93-8
pubmed: 21037284
Children (Basel). 2021 Feb 11;8(2):
pubmed: 33670260
Dtsch Arztebl Int. 2019 Mar 8;116(11):177-183
pubmed: 31014448
Clin Perinatol. 2016 Dec;43(4):799-816
pubmed: 27837760
Neonatology. 2021;118(3):325-331
pubmed: 33827081
J Neonatal Perinatal Med. 2017;10(3):267-273
pubmed: 28854512
J Pediatr. 2015 Feb;166(2):240-4.e1
pubmed: 25454938
JAMA. 2018 Jun 5;319(21):2190-2201
pubmed: 29872859
J Pediatr. 2015 Sep;167(3):545-50.e1-2
pubmed: 26144575
Cochrane Database Syst Rev. 2016 Dec 15;12:CD005384
pubmed: 27976361
Pediatr Pulmonol. 2021 Jul;56(7):2067-2072
pubmed: 33773084
Neonatology. 2015;107(3):199-205
pubmed: 25660143
Am J Respir Crit Care Med. 2021 Nov 15;204(10):1192-1199
pubmed: 34428130
Arch Dis Child Fetal Neonatal Ed. 2022 Sep;107(5):539-544
pubmed: 35140115
Cochrane Database Syst Rev. 2017 Feb 01;2:CD003212
pubmed: 28146296
JAMA. 2015 Aug 11;314(6):595-603
pubmed: 26262797
Arch Dis Child Fetal Neonatal Ed. 2013 Sep;98(5):F392-8
pubmed: 23457220
J Clin Med. 2020 Jul 15;9(7):
pubmed: 32679682
Neonatology. 2016;109(1):6-13
pubmed: 26394387
Eur J Pediatr. 2022 Jan;181(1):215-223
pubmed: 34254173
Int J Mol Sci. 2021 Oct 02;22(19):
pubmed: 34639034
Arch Dis Child Fetal Neonatal Ed. 2022 Jan;107(1):39-44
pubmed: 33963005
Pediatr Res. 2012 Dec;72(6):606-12
pubmed: 23037873